Hepatitis A Vaccine Market - Global Outlook and Forecast 2021-2027

Publisher Name :
Date: 30-Jan-2021
No. of pages: 92

This report contains market size and forecasts of Hepatitis A Vaccine in global, including the following market information:

Global Hepatitis A Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Hepatitis A Vaccine Market Sales, 2016-2021, 2022-2027, (K MT)

Global top five Hepatitis A Vaccine companies in 2020 (%)

The global Hepatitis A Vaccine market was valued at 712.4 million in 2020 and is projected to reach US$ 771.5 million by 2027, at a CAGR of 2.0% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatitis A Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hepatitis A Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)

Global Hepatitis A Vaccine Market Segment Percentages, By Type, 2020 (%)

- Inactivated Vaccine

- Live Attenuated Vaccine

Global Hepatitis A Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)

Global Hepatitis A Vaccine Market Segment Percentages, By Application, 2020 (%)

- Government Institution

- Private Sector

- Other

Global Hepatitis A Vaccine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K MT)

Global Hepatitis A Vaccine Market Segment Percentages, By Region and Country, 2020 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hepatitis A Vaccine revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Hepatitis A Vaccine revenues share in global market, 2020 (%)

Key companies Hepatitis A Vaccine sales in global market, 2016-2021 (Estimated), (K MT)

Key companies Hepatitis A Vaccine sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- GSK

- Merck

- Sanofi

- Sinovac

- Zhejiang Pukang

- Changchun Institute of Biological

- KM Biologics

- IMBCA

- ChangSheng

- Convac

Hepatitis A Vaccine Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Hepatitis A Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis A Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis A Vaccine Overall Market Size
2.1 Global Hepatitis A Vaccine Market Size: 2021 VS 2027
2.2 Global Hepatitis A Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Hepatitis A Vaccine Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Hepatitis A Vaccine Players in Global Market
3.2 Top Global Hepatitis A Vaccine Companies Ranked by Revenue
3.3 Global Hepatitis A Vaccine Revenue by Companies
3.4 Global Hepatitis A Vaccine Sales by Companies
3.5 Global Hepatitis A Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Hepatitis A Vaccine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Hepatitis A Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis A Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Hepatitis A Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatitis A Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hepatitis A Vaccine Market Size Markets, 2021 & 2027
4.1.2 Inactivated Vaccine
4.1.3 Live Attenuated Vaccine
4.2 By Type - Global Hepatitis A Vaccine Revenue & Forecasts
4.2.1 By Type - Global Hepatitis A Vaccine Revenue, 2016-2021
4.2.2 By Type - Global Hepatitis A Vaccine Revenue, 2022-2027
4.2.3 By Type - Global Hepatitis A Vaccine Revenue Market Share, 2016-2027
4.3 By Type - Global Hepatitis A Vaccine Sales & Forecasts
4.3.1 By Type - Global Hepatitis A Vaccine Sales, 2016-2021
4.3.2 By Type - Global Hepatitis A Vaccine Sales, 2022-2027
4.3.3 By Type - Global Hepatitis A Vaccine Sales Market Share, 2016-2027
4.4 By Type - Global Hepatitis A Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis A Vaccine Market Size, 2021 & 2027
5.1.2 Government Institution
5.1.3 Private Sector
5.1.4 Other
5.2 By Application - Global Hepatitis A Vaccine Revenue & Forecasts
5.2.1 By Application - Global Hepatitis A Vaccine Revenue, 2016-2021
5.2.2 By Application - Global Hepatitis A Vaccine Revenue, 2022-2027
5.2.3 By Application - Global Hepatitis A Vaccine Revenue Market Share, 2016-2027
5.3 By Application - Global Hepatitis A Vaccine Sales & Forecasts
5.3.1 By Application - Global Hepatitis A Vaccine Sales, 2016-2021
5.3.2 By Application - Global Hepatitis A Vaccine Sales, 2022-2027
5.3.3 By Application - Global Hepatitis A Vaccine Sales Market Share, 2016-2027
5.4 By Application - Global Hepatitis A Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Hepatitis A Vaccine Market Size, 2021 & 2027
6.2 By Region - Global Hepatitis A Vaccine Revenue & Forecasts
6.2.1 By Region - Global Hepatitis A Vaccine Revenue, 2016-2021
6.2.2 By Region - Global Hepatitis A Vaccine Revenue, 2022-2027
6.2.3 By Region - Global Hepatitis A Vaccine Revenue Market Share, 2016-2027
6.3 By Region - Global Hepatitis A Vaccine Sales & Forecasts
6.3.1 By Region - Global Hepatitis A Vaccine Sales, 2016-2021
6.3.2 By Region - Global Hepatitis A Vaccine Sales, 2022-2027
6.3.3 By Region - Global Hepatitis A Vaccine Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Hepatitis A Vaccine Revenue, 2016-2027
6.4.2 By Country - North America Hepatitis A Vaccine Sales, 2016-2027
6.4.3 US Hepatitis A Vaccine Market Size, 2016-2027
6.4.4 Canada Hepatitis A Vaccine Market Size, 2016-2027
6.4.5 Mexico Hepatitis A Vaccine Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Hepatitis A Vaccine Revenue, 2016-2027
6.5.2 By Country - Europe Hepatitis A Vaccine Sales, 2016-2027
6.5.3 Germany Hepatitis A Vaccine Market Size, 2016-2027
6.5.4 France Hepatitis A Vaccine Market Size, 2016-2027
6.5.5 U.K. Hepatitis A Vaccine Market Size, 2016-2027
6.5.6 Italy Hepatitis A Vaccine Market Size, 2016-2027
6.5.7 Russia Hepatitis A Vaccine Market Size, 2016-2027
6.5.8 Nordic Countries Hepatitis A Vaccine Market Size, 2016-2027
6.5.9 Benelux Hepatitis A Vaccine Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Hepatitis A Vaccine Revenue, 2016-2027
6.6.2 By Region - Asia Hepatitis A Vaccine Sales, 2016-2027
6.6.3 China Hepatitis A Vaccine Market Size, 2016-2027
6.6.4 Japan Hepatitis A Vaccine Market Size, 2016-2027
6.6.5 South Korea Hepatitis A Vaccine Market Size, 2016-2027
6.6.6 Southeast Asia Hepatitis A Vaccine Market Size, 2016-2027
6.6.7 India Hepatitis A Vaccine Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Hepatitis A Vaccine Revenue, 2016-2027
6.7.2 By Country - South America Hepatitis A Vaccine Sales, 2016-2027
6.7.3 Brazil Hepatitis A Vaccine Market Size, 2016-2027
6.7.4 Argentina Hepatitis A Vaccine Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hepatitis A Vaccine Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Hepatitis A Vaccine Sales, 2016-2027
6.8.3 Turkey Hepatitis A Vaccine Market Size, 2016-2027
6.8.4 Israel Hepatitis A Vaccine Market Size, 2016-2027
6.8.5 Saudi Arabia Hepatitis A Vaccine Market Size, 2016-2027
6.8.6 UAE Hepatitis A Vaccine Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Corporate Summary
7.1.2 GSK Business Overview
7.1.3 GSK Hepatitis A Vaccine Major Product Offerings
7.1.4 GSK Hepatitis A Vaccine Sales and Revenue in Global (2016-2021)
7.1.5 GSK Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Hepatitis A Vaccine Major Product Offerings
7.2.4 Merck Hepatitis A Vaccine Sales and Revenue in Global (2016-2021)
7.2.5 Merck Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Hepatitis A Vaccine Major Product Offerings
7.3.4 Sanofi Hepatitis A Vaccine Sales and Revenue in Global (2016-2021)
7.3.5 Sanofi Key News
7.4 Sinovac
7.4.1 Sinovac Corporate Summary
7.4.2 Sinovac Business Overview
7.4.3 Sinovac Hepatitis A Vaccine Major Product Offerings
7.4.4 Sinovac Hepatitis A Vaccine Sales and Revenue in Global (2016-2021)
7.4.5 Sinovac Key News
7.5 Zhejiang Pukang
7.5.1 Zhejiang Pukang Corporate Summary
7.5.2 Zhejiang Pukang Business Overview
7.5.3 Zhejiang Pukang Hepatitis A Vaccine Major Product Offerings
7.5.4 Zhejiang Pukang Hepatitis A Vaccine Sales and Revenue in Global (2016-2021)
7.5.5 Zhejiang Pukang Key News
7.6 Changchun Institute of Biological
7.6.1 Changchun Institute of Biological Corporate Summary
7.6.2 Changchun Institute of Biological Business Overview
7.6.3 Changchun Institute of Biological Hepatitis A Vaccine Major Product Offerings
7.6.4 Changchun Institute of Biological Hepatitis A Vaccine Sales and Revenue in Global (2016-2021)
7.6.5 Changchun Institute of Biological Key News
7.7 KM Biologics
7.7.1 KM Biologics Corporate Summary
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Hepatitis A Vaccine Major Product Offerings
7.4.4 KM Biologics Hepatitis A Vaccine Sales and Revenue in Global (2016-2021)
7.7.5 KM Biologics Key News
7.8 IMBCA
7.8.1 IMBCA Corporate Summary
7.8.2 IMBCA Business Overview
7.8.3 IMBCA Hepatitis A Vaccine Major Product Offerings
7.8.4 IMBCA Hepatitis A Vaccine Sales and Revenue in Global (2016-2021)
7.8.5 IMBCA Key News
7.9 ChangSheng
7.9.1 ChangSheng Corporate Summary
7.9.2 ChangSheng Business Overview
7.9.3 ChangSheng Hepatitis A Vaccine Major Product Offerings
7.9.4 ChangSheng Hepatitis A Vaccine Sales and Revenue in Global (2016-2021)
7.9.5 ChangSheng Key News
7.10 Convac
7.10.1 Convac Corporate Summary
7.10.2 Convac Business Overview
7.10.3 Convac Hepatitis A Vaccine Major Product Offerings
7.10.4 Convac Hepatitis A Vaccine Sales and Revenue in Global (2016-2021)
7.10.5 Convac Key News
8 Global Hepatitis A Vaccine Production Capacity, Analysis
8.1 Global Hepatitis A Vaccine Production Capacity, 2016-2027
8.2 Hepatitis A Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatitis A Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hepatitis A Vaccine Supply Chain Analysis
10.1 Hepatitis A Vaccine Industry Value Chain
10.2 Hepatitis A Vaccine Upstream Market
10.3 Hepatitis A Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatitis A Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Hepatitis A Vaccine in Global Market
Table 2. Top Hepatitis A Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Hepatitis A Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Hepatitis A Vaccine Revenue Share by Companies, 2016-2021
Table 5. Global Hepatitis A Vaccine Sales by Companies, (K MT), 2016-2021
Table 6. Global Hepatitis A Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Hepatitis A Vaccine Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Hepatitis A Vaccine Product Type
Table 9. List of Global Tier 1 Hepatitis A Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis A Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Hepatitis A Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Hepatitis A Vaccine Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Hepatitis A Vaccine Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Hepatitis A Vaccine Sales (K MT), 2016-2021
Table 15. By Type - Global Hepatitis A Vaccine Sales (K MT), 2022-2027
Table 16. By Application - Global Hepatitis A Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Hepatitis A Vaccine Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Hepatitis A Vaccine Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Hepatitis A Vaccine Sales (K MT), 2016-2021
Table 20. By Application - Global Hepatitis A Vaccine Sales (K MT), 2022-2027
Table 21. By Region - Global Hepatitis A Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Hepatitis A Vaccine Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Hepatitis A Vaccine Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Hepatitis A Vaccine Sales (K MT), 2016-2021
Table 25. By Region - Global Hepatitis A Vaccine Sales (K MT), 2022-2027
Table 26. By Country - North America Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Hepatitis A Vaccine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Hepatitis A Vaccine Sales, (K MT), 2016-2021
Table 29. By Country - North America Hepatitis A Vaccine Sales, (K MT), 2022-2027
Table 30. By Country - Europe Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Hepatitis A Vaccine Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Hepatitis A Vaccine Sales, (K MT), 2016-2021
Table 33. By Country - Europe Hepatitis A Vaccine Sales, (K MT), 2022-2027
Table 34. By Region - Asia Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Hepatitis A Vaccine Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Hepatitis A Vaccine Sales, (K MT), 2016-2021
Table 37. By Region - Asia Hepatitis A Vaccine Sales, (K MT), 2022-2027
Table 38. By Country - South America Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Hepatitis A Vaccine Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Hepatitis A Vaccine Sales, (K MT), 2016-2021
Table 41. By Country - South America Hepatitis A Vaccine Sales, (K MT), 2022-2027
Table 42. By Country - Middle East & Africa Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Hepatitis A Vaccine Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Hepatitis A Vaccine Sales, (K MT), 2016-2021
Table 45. By Country - Middle East & Africa Hepatitis A Vaccine Sales, (K MT), 2022-2027
Table 46. GSK Corporate Summary
Table 47. GSK Hepatitis A Vaccine Product Offerings
Table 48. GSK Hepatitis A Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 49. Merck Corporate Summary
Table 50. Merck Hepatitis A Vaccine Product Offerings
Table 51. Merck Hepatitis A Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Hepatitis A Vaccine Product Offerings
Table 54. Sanofi Hepatitis A Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 55. Sinovac Corporate Summary
Table 56. Sinovac Hepatitis A Vaccine Product Offerings
Table 57. Sinovac Hepatitis A Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 58. Zhejiang Pukang Corporate Summary
Table 59. Zhejiang Pukang Hepatitis A Vaccine Product Offerings
Table 60. Zhejiang Pukang Hepatitis A Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 61. Changchun Institute of Biological Corporate Summary
Table 62. Changchun Institute of Biological Hepatitis A Vaccine Product Offerings
Table 63. Changchun Institute of Biological Hepatitis A Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 64. KM Biologics Corporate Summary
Table 65. KM Biologics Hepatitis A Vaccine Product Offerings
Table 66. KM Biologics Hepatitis A Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 67. IMBCA Corporate Summary
Table 68. IMBCA Hepatitis A Vaccine Product Offerings
Table 69. IMBCA Hepatitis A Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 70. ChangSheng Corporate Summary
Table 71. ChangSheng Hepatitis A Vaccine Product Offerings
Table 72. ChangSheng Hepatitis A Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 73. Convac Corporate Summary
Table 74. Convac Hepatitis A Vaccine Product Offerings
Table 75. Convac Hepatitis A Vaccine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 76. Hepatitis A Vaccine Production Capacity (K MT) of Key Manufacturers in Global Market, 2019-2021 (K MT)
Table 77. Global Hepatitis A Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 78. Global Hepatitis A Vaccine Production by Region, 2016-2021 (K MT)
Table 79. Global Hepatitis A Vaccine Production by Region, 2022-2027 (K MT)
Table 80. Hepatitis A Vaccine Market Opportunities & Trends in Global Market
Table 81. Hepatitis A Vaccine Market Drivers in Global Market
Table 82. Hepatitis A Vaccine Market Restraints in Global Market
Table 83. Hepatitis A Vaccine Raw Materials
Table 84. Hepatitis A Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Hepatitis A Vaccine Downstream
Table 86. Hepatitis A Vaccine Downstream Clients in Global Market
Table 87. Hepatitis A Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hepatitis A Vaccine Segment by Type
Figure 2. Hepatitis A Vaccine Segment by Application
Figure 3. Global Hepatitis A Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Hepatitis A Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Hepatitis A Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Hepatitis A Vaccine Sales in Global Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis A Vaccine Revenue in 2020
Figure 9. By Type - Global Hepatitis A Vaccine Sales Market Share, 2016-2027
Figure 10. By Type - Global Hepatitis A Vaccine Revenue Market Share, 2016-2027
Figure 11. By Type - Global Hepatitis A Vaccine Price (USD/MT), 2016-2027
Figure 12. By Application - Global Hepatitis A Vaccine Sales Market Share, 2016-2027
Figure 13. By Application - Global Hepatitis A Vaccine Revenue Market Share, 2016-2027
Figure 14. By Application - Global Hepatitis A Vaccine Price (USD/MT), 2016-2027
Figure 15. By Region - Global Hepatitis A Vaccine Sales Market Share, 2016-2027
Figure 16. By Region - Global Hepatitis A Vaccine Revenue Market Share, 2016-2027
Figure 17. By Country - North America Hepatitis A Vaccine Revenue Market Share, 2016-2027
Figure 18. By Country - North America Hepatitis A Vaccine Sales Market Share, 2016-2027
Figure 19. US Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Hepatitis A Vaccine Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Hepatitis A Vaccine Sales Market Share, 2016-2027
Figure 24. Germany Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 25. France Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Hepatitis A Vaccine Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Hepatitis A Vaccine Sales Market Share, 2016-2027
Figure 33. China Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 37. India Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Hepatitis A Vaccine Revenue Market Share, 2016-2027
Figure 39. By Country - South America Hepatitis A Vaccine Sales Market Share, 2016-2027
Figure 40. Brazil Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Hepatitis A Vaccine Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Hepatitis A Vaccine Sales Market Share, 2016-2027
Figure 44. Turkey Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Hepatitis A Vaccine Revenue, (US$, Mn), 2016-2027
Figure 48. Global Hepatitis A Vaccine Production Capacity (K MT), 2016-2027
Figure 49. The Percentage of Production Hepatitis A Vaccine by Region, 2020 VS 2027
Figure 50. Hepatitis A Vaccine Industry Value Chain
Figure 51. Marketing Channels
  • Global Hepatitis A Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 89
    According to our LPI (LP Information) latest study, the global Hepatitis A Vaccine market size was valued at US$ 690.5 million in 2023. With growing demand in downstream market, the Hepatitis A Vaccine is forecast to a readjusted size of US$ 810.9 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Hepatitis A Vaccine market. Hepatitis A Vaccine are expected to show stable growth in the future market. However, produc......
  • Global Human Hepatitis B Immunoglobulin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 127
    Market Overview of Global Human Hepatitis B Immunoglobulin market: According to our latest research, the global Human Hepatitis B Immunoglobulin market looks promising in the next 5 years. As of 2022, the global Human Hepatitis B Immunoglobulin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......
  • Global Hepatitis A Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 85
    According to our (Global Info Research) latest study, the global Hepatitis A Vaccine market size was valued at USD 726.3 million in 2023 and is forecast to a readjusted size of USD 842.5 million by 2030 with a CAGR of 2.1% during review period. Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currentl......
  • Global Hepatitis A Vaccine Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117
    Report Overview: Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 ye......
  • Global Thymosin a1 Professional Survey Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 103
    Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......
  • Global Thymosin a1 Market Research Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 136
    Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......
  • Global Hepatitis B Immune Globulin Market Research Report 2023
    Published: 06-Nov-2023        Price: US 2900 Onwards        Pages: 85
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hepatitis B Immune Globulin market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - ADMA Biologics - Bio Products Laboratory - Grifols - Biotest AG - CSL Behring - FFF Enterprises - Cleveland Clinic Seg......
  • Global Sofosbuvir Market Research Report 2023
    Published: 31-Oct-2023        Price: US 2900 Onwards        Pages: 94
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sofosbuvir market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Teva Pharmaceutical Industries Ltd - DONG BANG FUTURE TECH & LIFE CO., LTD - Beaukev Pharma International Pvt.Ltd - DEAFARMA - Tecoland - Anhui HaiKang Pha......
  • Global Hepatitis A Vaccine Market Insights, Forecast to 2029
    Published: 22-Sep-2023        Price: US 4900 Onwards        Pages: 97
    Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs